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SUPPLEMENT

HELPinKids&Adults Knowledge Synthesis of the
Management of Vaccination Pain and
High Levels of Needle Fear
Limitations of the Evidence and
Recommendations for Future Research
Melanie Noel, PhD,* Anna Taddio, PhD,w C. Meghan McMurtry, PhD,z
Christine T. Chambers, PhD, R Psych,y Rebecca Pillai Riddell, PhD,8
Vibhuti Shah, MD,z and HELPinKids&Adults Team

Abstract: The HELPinKids&Adults knowledge synthesis for the
management of vaccination-related pain and high levels of needle
fear updated and expanded upon the 2010 HELPinKIDS knowledge
synthesis and clinical practice guideline for pain mitigation during
vaccine injections in childhood. Interventions for vaccine pain management in adults and treatment of individuals with high levels of
needle fear, phobias, or both were included, thereby broadening the
reach of this work. The present paper outlines the overarching limitations of this diverse evidence base and provides recommendations
for future research. Consistent with the framing of clinical questions
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in the systematic reviews, the Participants, Intervention, Comparison,
Outcome, Study design (PICOAS) framework was used to organize
these predominant issues and research directions. The major limitations we identiﬁed across systematic reviews were an overall dearth
of trials on vaccination, lack of methodological rigor, failure to
incorporate important outcomes, poor study reporting, and various
sources of heterogeneity. Future research directions in terms of
conducting additional trials in the vaccination context, improving
methodological quality and rigor, assessment of global acceptability
and feasibility of interventions, and inclusion of outcomes that
stakeholders consider to be important (eg, compliance) are recommended. Given concerns about pain and fear are known contributors
to vaccine hesitancy, improving and expanding this evidence base will
be integral to broader eﬀorts to improve vaccine compliance and
public health worldwide.
Key Words: pain management, randomized-controlled trials, systematic review, vaccination, injection techniques

(Clin J Pain 2015;31:S124–S131)

T

he HELPinKids&Adults knowledge synthesis for the
management of vaccination-related pain and treatment of
individuals with high levels of needle fear described in the
preceding articles in this special issue of the Clinical Journal of
Pain updated and expanded upon the 2010 HELPinKIDS
knowledge synthesis and clinical practice guideline for the
management of acute pain during childhood vaccine injections.1 Speciﬁcally, adults and individuals with high levels of
needle fear were added, leading to a synthesis of the research
evidence that considers both acute and longer-term issues
associated with unmitigated pain and is generalizable to a
wider variety of individuals and contexts. Gaps were uncovered across the evidence base that are worthy of discussion.
Analysis of these shortcomings illuminate important avenues
for future research that can serve to improve the quality of
the results, and thereby lead to increased conﬁdence in how
to optimally manage vaccination pain and related issues
across the lifespan. The objectives of this manuscript are to:
(1) highlight limitations in the research evidence that span
diﬀerent domains of pain and fear management included in
the systematic reviews in this issue; and (2) identify the most
important avenues for future investigations in this area.
Consistent with the framing of clinical questions in the systematic reviews, the Participants, Intervention, Comparison,
Outcome, Study Design (PICOS, Table 1) framework was
used to organize these predominant issues and research
directions; this information is summarized in Table 2.
Clin J Pain
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Limitations and Future Directions

TABLE 1. PICOS Criteria for Clinical Questions

Items

Deﬁnition

P (participants)
I (intervention)

C (comparison)

O (outcomes)

S (study design)

Individuals of all ages undergoing vaccine injections in inpatient and outpatient settings, including
schools. If no data existed for vaccine injections, then the closest-related procedure or context was
included (eg, venipuncture in outpatient clinic)
Single and combination interventions used for the management of pain* during or related to vaccine
injections, including: procedural strategies, physical strategies, pharmacological strategies,
psychological (and information provision) strategies, and process (education, implementation, or
both) strategies. If no interventions existed for pain during or related to vaccine injections, literature
was examined on interventions for the closest-related procedure or context (eg, venipuncture).
Comparisons included no treatment (ie, no documented intervention above usual care) or speciﬁed
comparators (eg, placebo). Cointerventions were allowed depending on the clinical question.
Additive beneﬁts of an intervention over other(s) were also examined separately according to the
clinical question.
Outcomes included: pain and pain-related outcomes (eg, fear, distress), preferences, satisfaction,
fainting, procedure outcomes (eg, duration, success), parent fear, knowledge about pain
interventions, pain intervention utilization, safety outcomes, vaccine compliance, memory, or more
than one. Pain, fear, distress, or any of the three were typically prioritized as critically important
outcomes across clinical questions.
Randomized and quasirandomized-controlled trials were included

*Other outcomes may have been prioritized.

PARTICIPANTS
Age and Developmental Issues
In undertaking analyses for the diﬀerent interventions
examined in the HELPinKids&Adults knowledge synthesis,
age was often identiﬁed a priori to be an important factor in
judging the eﬀectiveness of a given intervention. As such,
age groupings were customized for each analysis. For
example, distraction was analyzed for young children (up to
3 y) separately from children (> 3 to 12 y), adolescents
(> 12 to 17 y), and adults (18 y and above). For other
clinical questions, broader age groupings (eg, 3 to 17 y)
were maintained. Age distinctions were empirically supported based on dramatic biological, cognitive, and social
changes occurring across infancy, childhood, and adolescence that can inﬂuence the pain experience.2–4 Moreover, the Standards for Research in Child Health, an
international initiative established to improve reliability
and relevance of pediatric clinical trials, has also advocated
for consideration of age.5
Our developmental approach to analyses revealed
important diﬀerences between age groups in the eﬃcacy of
particular interventions that would otherwise not have been
revealed. However, the available age divisions often encompassed several developmental periods which may have
introduced confounds given developmental diﬀerences in
pain expression and measurement,6 pain processing,4,7,8
cognitive and coping abilities,9 and potential beneﬁt derived
from individual interventions.10,11 For example, with respect
to distraction, children between 0 and 3 years were treated as
1 homogeneous group due to the fact that they were often
lumped together in included trials. Moreover, evidence was
scant or unavailable for particular age groups and populations (adolescents, adults, elderly), thereby limiting our
ability to examine eﬀectiveness in speciﬁc age groups. We
were cautious in our approach to extrapolating results across
all individuals; however, we recommend future research that
allows more detailed examination of developmental issues.

Individual Comorbidities and Differences
Study samples included in the systematic reviews were
variable. Studies could have included individuals with and
Copyright
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without chronic illnesses, comorbidities (eg, cancer, depression,
autism, cognitive impairments), previous experiences with
painful procedures, or any of these that would have resulted in
diﬀerent pain learning histories and thereby inﬂuenced ones
response to vaccination. Pain during past painful procedures
predicts future pain and may inﬂuence the likelihood of beneﬁtting from pain management interventions.12 Individual
diﬀerences in cognitions about pain may also impact one’s
ability to beneﬁt from certain evidence-based psychological
interventions. For example, catastrophic thinking about pain
(ie, the cognitive tendency to magnify and perseverate on the
threat value of pain and perceive oneself as being helpless in
the face of pain) has been shown to impede analgesic eﬀects of
distraction,13 a psychological intervention that has demonstrated eﬃcacy for children and adolescents.14 Such individual
diﬀerences could have introduced heterogeneity into the data
and inﬂuenced the magnitude of treatment eﬀects. Recommendations for future research include more detailed reporting
of participant characteristics, potential stratiﬁcation by prognostic criteria such as level of fear, and reporting of results for
subgroups with diﬀerent characteristics.

Heterogeneity Within the Vaccination Context
There was considerable variability in the vaccination
procedure among included studies which may have inﬂuenced results including: the number and type of vaccines
given, how they were given, as well as the setting in which
they were given. Variability in operator techniques alone
could have led to signiﬁcant diﬀerences in pain, including:
injection method (aspiration vs. no aspiration), route of
administration (subcutaneous vs. intramuscular), and site
of administration (arm vs. leg). All of these factors may
aﬀect how an intervention works and we could not examine
all of these variables. In fact, authors often failed to provide
this information. It is important to note, however, that
when treatment eﬀects are revealed in the presence of this
variability, it gives more conﬁdence in the results, as this
variability is reﬂective of how interventions are routinely
administered in the real world.
Important research gaps were identiﬁed, such as the
relative painfulness of individual vaccines (which informs
their order of administration), the eﬀects of injecting the

2015 Wolters Kluwer Health, Inc. All rights reserved.
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TABLE 2. Summary of Limitations of Research Evidence Across Systematic Reviews and Future Research Directions

PICOS
Category

Limitations of the Evidence

Future Research Directions

Participants

Age/developmental issues
Age divisions included several developmental periods
(constrained by evidence base)
Lack of data
Limited evidence in adolescence and adulthood; no
evidence for individuals with cognitive impairment
Heterogeneity
Lack of assessment of individual factors (eg, comorbidities,
preferred coping strategies)
Variability in vaccines and their delivery (eg, route, site of
administration)
Indirectness
Indirect evidence from nonvaccination contexts (eg,
venipuncture)
Interventions Lack of data
Adolescent, adult, and infant psychological interventions,
education and preparation interventions, interventions for
individuals with high needle fears
Memory reframing interventions
Environment/setting factors
Teaching interventionists and individuals being vaccinated
about vaccination pain management
Acceptability in various (especially nonwestern) cultural
groups
Heterogeneity
Intervention delivery
Cointerventions (poor reporting)
Outdated technologies
Distraction
Comparisons Suitability
Unclear whether particular comparison groups were
appropriate/comparable across studies; poor reporting
Lack of blinding
Participant knowledge of no treatment condition
Heterogeneity
Active control, no treatment control, placebo

(1) Consideration of age and developmental stage when
designing and evaluating interventions (eg, analyze
eﬀectiveness in tighter age groups)
(2) Examination of underrepresented age groups and
populations (eg, adolescents, adults, elderly, individuals
with diminished cognition)
(3) Inclusion and thorough assessment and reporting of
individual characteristics to examine treatment moderators
(4) Improved reporting on vaccines (type and mode of
delivery)
(5) Additional research in the vaccination context

Outcomes

(1) Inclusion of tools with established psychometric
properties to assess vaccination outcomes
(2) Development of new outcome measures where needed
(3) Inclusion of outcomes deemed important by stakeholders
(4) Examination of postvaccination outcomes (eg, memory,
delayed pain, compliance)

Heterogeneity
Measures and methodologies (assessment timepoints,
assessors)
Combining diﬀerent measures of an outcome and same
outcome across time epochs
Lack of data for outcomes deemed important by stakeholders
Vaccination compliance, procedure outcomes, memory,
satisfaction, preferences, ﬁdelity
Long-term impact of interventions
Study design Lack of methodological rigor
Low-quality to very–low-quality evidence
Poor reporting of study details relevant to risk of bias
Predominance of “single-dose” studies that do not examine
longer-term response to consistent pain management

(1) Additional trials of interventions lacking data using
current technologies
(2) Additional trials of underrepresented interventions for
individuals across the lifespan in the vaccination context
(3) Focus on feasible interventions that are acceptable across
cultures and geographical regions
(4) Examination of vaccination setting and environment, (eg,
school-based contexts)
(5) Investigation of best practices for teaching vaccination
pain management to parents, immunizers, individuals
undergoing immunization
(6) Improved reporting on use of cointerventions

(1) Use of appropriate comparison conditions balancing
clinical relevance and scientiﬁc rigor
(2) Improved reporting on nature of comparison group
(3) Adequate blinding
(4) Increased methodological rigor

(1) Well-designed RCTs in the context of vaccination across
all ages
(2) Adherence to CONSORT and Cochrane Collaboration
methodology when designing RCTs
(3) Consideration of developmental stage and use of a
multidisciplinary approach when designing trials
(4) Prospective, longitudinal designs

PICOS indicates Participants, Intervention, Comparison, Outcome, Study design; RCTs, randomized-controlled trial.

same versus multiple limbs, as well as aspects about the
vaccine supplies themselves (eg, needle size and injection
speed) on pain and fear. These technical aspects of vaccination are particularly relevant to study as they are costneutral and hence, implementable on a global level.

Indirectness: Reliance on Nonvaccination contexts
Across some of the clinical questions, there were gaps
in research evidence with respect to the eﬀect of

S126 | www.clinicalpain.com

interventions among individuals undergoing vaccination,
and we were sometimes required to draw from research
outside of the vaccination context (eg, venipunctures). This
was the case for interventions pertaining to individuals with
high needle fears, distraction for adults, and muscle tension.
Indirect evidence was only considered in the absence of
direct evidence to provide guidance across diﬀerent ages
and interventions. Nevertheless, there are potential problems with this approach. For example, young children have

Copyright
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reported that discomfort is considerably higher in response
to venipunctures than to vaccinations.15 In contrast, multiple vaccines are usually administered in 1 visit, which can
lead to more pain. It is also important to consider that the
particular cognitions driving needle fears, pain, and distress
may diﬀer by individual and procedure type. Individuals
may fear, become distressed, or both by drawing or seeing
blood, the injection or puncture itself, the medical procedure context, or the insertion of a foreign substance into
ones’ body. The focus of the fear would be expected to
inﬂuence the pain experience and vary as function of the
type of procedure (venipuncture, vaccination); therefore,
there are several potential limitations in extrapolating
ﬁndings from nonvaccination to vaccination contexts.
These aforementioned issues were not accounted for in the
evidence base and their contribution to the variability in the
observed eﬀectiveness of diﬀerent interventions is
unknown. More research in the vaccination context is
critically needed to provide a speciﬁc evidence base that
is directly relevant.

INTERVENTIONS
Lack of Trials
The systematic reviews covered a diverse range of
interventions spanning procedural, physical, pharmacological, psychological, and process domains. Psychological
and physical interventions for needle fear speciﬁcally were
reviewed separately. Although some interventions (eg,
breastfeeding, topical anesthetics, and sweet tasting solutions) were well studied and included large samples, the
majority, by comparison, were signiﬁcantly understudied
(eg, adult, adolescent, and infant psychological interventions, education and preparation interventions, interventions for individuals with high needle fears). The lack of
data for many interventions limits our ability to have
conﬁdence in the ﬁndings. Indeed, some of the ﬁndings
included in this series are based on a single study of low or
very low quality. Thus, recommendations based on this
limited evidence base could be changed or reversed when
these meta-analyses are updated with additional trials in the
future. Additional research on these understudied interventions is needed to better characterize their impact on
critical and important outcomes.

Heterogeneity in Intervention Delivery
There was considerable heterogeneity in the way that
interventions were delivered that may impact results. For
example, manual tactile stimulation was delivered by rubbing, tapping, and applying pressure at diﬀerent time
epochs of vaccination. There was even greater variability in
psychological interventions, such as distraction, including
who delivered the intervention (eg, parent, nurse), the
degree of sophistication of the distractor and engagement it
evoked (eg, high-technology robots, low-technology toys,
verbal comments about non–procedure-related things), and
the timing of when the intervention was actually administered (eg, before, during, after the needle). Such variability
in intervention delivery can inﬂuence its eﬀectiveness; furthermore, given the generally small sample sizes available,
diﬀerences may have been obscured. Taken together, variability in how interventions were delivered would be
expected to have added noise to the data and reduced the
precision and conﬁdence in the results. With additional
Copyright
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Limitations and Future Directions

trials of interventions delivered in similar ways, we will be
able to examine the eﬃcacy of each method separately.

Outdated Technologies and Cultural
Appropriateness
Given rapid changes in electronic technology, the mode
of delivery for some interventions in included studies is not
consistent with current methods of delivery (eg, video distraction was delivered via a DVD or television rather than an
interactive Smartphone or iPad, which would arguably be
more engaging); the eﬀectiveness may be diﬀerent for these
diﬀerent modes of delivery. Related to this issue is the lack of
data for the delivery of interventions that are more globally
accessible, feasible (eg, music delivered via singing rather than
with headphones), and acceptable. Many included interventions may not be globally applicable, in terms of cultural
appropriateness, cost, feasibility, political climate, or any of
these. This research is critically needed to broaden the reach
of this evidence to individuals worldwide.

Underrepresented Interventions
There were also clinical questions initially considered
by the HELPinKids&Adults team for inclusion in the systematic reviews that were subsequently excluded because of
the lack of studies that adequately evaluated their eﬀects.
For example, psychological interventions designed to
reframe individuals’ memories about painful procedures
following injections were initially included among the trials
initially reviewed. However, concerns about indirectness of
the evidence (including youth with cancer undergoing
lumbar punctures16 and anesthetic injections during
restorative dental procedures17) and issues related to
deceiving individuals about pain and fear (eg, telling children that they did not cry18) were raised. In addition,
complex psychological interventions (eg, hypnosis) were
excluded as they are not feasible for clinicians administering
routine vaccinations.
Clinical questions pertaining to the environment or
setting in which a vaccination occurs were excluded in the
HELPinKids&Adults knowledge synthesis. It is likely that
aspects of the environment or setting inﬂuence ones experience (eg, consider a 10-y-old boy who is vaccinated in a
private, calm room in comparison to being vaccinated in a
gymnasium where he is surrounded by staring peers and
can witness his friends cry and potentially faint). Unfortunately, beyond focus groups and descriptive research,19–28
no trials were identiﬁed that systematically studied relevant
environmental factors such as: privacy, presence of peers,
ventilation, use of separate entrances and exits to the vaccination area, and concealing distress-provoking items.
Consideration of setting and situational factors in future
research is important, perhaps particularly for school-based
vaccination. Related to this, there is currently no literature
about how to eﬀectively teach youth about school-based
vaccinations. Research is needed to provide guidance about
how to optimally educate individuals being vaccinated
about vaccination pain and fear management. Furthermore, research is also needed to provide more detailed
guidance to relevant individuals (eg, immunizers, parents,
individuals being vaccinated) about how to actually
implement eﬀective interventions (eg, by expanding immunization manuals to include this information).
Finally, particular pharmacological interventions (ie,
nitrous oxide, midazolam, chloral hydrate) were not
included in the knowledge synthesis because the context for

2015 Wolters Kluwer Health, Inc. All rights reserved.
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routine vaccinations), or both and speciﬁc expertise and
monitoring equipment is required to ensure safe use.
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research to optimally translate into clinical practice, comparison conditions should be carefully selected.

Cointerventions

OUTCOMES

We did not systematically evaluate the eﬀect of cointerventions (eg, the eﬀect of distraction or sucrose in young
children in the presence of holding vs. lying supine) and
cointerventions were not consistently reported in the trials.
We highlighted cointerventions or examined the eﬀects of
an intervention with and without them when there were
available data and it was deemed important; however, this
was not consistent across clinical questions because of
limited data and poor reporting. We urge researchers to
thoroughly report on the use of cointerventions in trials.

COMPARISONS
Suitability of Comparison Groups
Various comparison groups were accepted in the
knowledge synthesis to evaluate the eﬀectiveness of diﬀerent interventions. We included no treatment control, placebo, and active control groups. The type of comparison
chosen depended on the clinical question. Some interventions consistently used strong comparison groups (eg,
placebo commonly used in trials of sucrose and topical
anesthetics), whereas others (eg, physical and psychological
interventions) utilized comparisons that were heterogeneous and raised questions about the validity of the study
ﬁndings. For instance, a “no treatment” comparison group
is subject to bias if it is known by participants that no
treatment is being given. This is particularly problematic
given that expectations regarding treatment response have
been shown to have robust eﬀects on treatment outcomes.29,30 Research suggests that studies that do not use
double-blinding substantially overestimate treatment
eﬀects, which in turn introduces bias.31,32 Studies included
in the knowledge synthesis examining psychological interventions were typically not blinded and included a no
treatment control group and therefore were subject to such
bias. This may have led to inaccurate conclusions about an
intervention’s eﬃcacy and more broadly, can lead to erroneous clinical decision making based on this evidence.33
It is also important to consider that the relevant
comparison groups may diﬀer vastly across clinical settings
and this variability is often reﬂective of the real world. For
example, researchers in some settings may have compared
breastfeeding during vaccination to lying supine, whereas
others compared breastfeeding to holding infants. In some
cases, the comparison intervention may even have an
impact on pain response. Across the interventions included
in the knowledge synthesis, the exact nature of the comparison conditions was often unclear, thereby making it
diﬃcult to ascertain the extent and impact that this variability had on results. When designing trials, researchers
should consider comparisons that both approximate the
real world and have methodological rigor. This presents a
challenge and often times a paradox for researchers but has
important implications for research and practice. For
example, although including a water placebo comparison
group in trials of sucrose is scientiﬁcally sound (ie, prevents
threats to internal validity), it does add complexity to trial
implementation and may limit generalizability (ie, giving
water does not approximate standard clinical care). For

S128 | www.clinicalpain.com

Primary Reliance on Self-Report of Pain
In the ﬁeld of pain, there is appreciation for the value of
incorporating multiple modes of measurement to collectively
capture the complexity of the pain experience. Nevertheless,
prioritization of certain outcomes as being more critical (eg,
self-reported pain vs. observer-rated pain) is often required to
facilitate decision making and was done for the HELPinKids&Adults knowledge synthesis. To mitigate the potential to dismiss interventions that might be associated with
some beneﬁts, we also considered secondary important outcomes (eg, observer-rated distress) in certain situations (eg,
for interventions with young children whose self-report of
pain may be unreliable and problematic6,34–37).
It is not clear how to optimally measure pain if not using
self-report. In the knowledge synthesis, we used currently
acceptable and valid measures.1,38 Recent research suggests
that electroencephalography may provide a more sensitive
indicator of nociceptive response to vaccination among
infants up to 1 year than traditional behavioral measures39
and other research highlights the incongruence between
behavioral measures and electroencephalography.40,41 This
raises important questions about the optimal way of measuring the eﬀectiveness of pain interventions across the lifespan and more fundamentally, what aspect of the pain
experience it is that we are measuring. However, feasibility of
assessment methods and “observability” of eﬀects of interventions are important considerations to facilitate “buy in”
of interventions and practice change.

Heterogeneity in Outcome Measurement
There was remarkable variability in the measurement
of eﬀectiveness across interventions in the knowledge synthesis. Systematic reviews included trials employing diﬀerent observational and self-report measurement tools and
methodologies (eg, video, real time), as well as assessment
time periods (eg, ranging from seconds to minutes before
and following the injection) and assessors (eg, observer,
parent, individual). It is likely that the methods used contributed to variability in the results and the overall ﬁndings.
In addition, the eﬀects of diﬀerent interventions were
measured at diﬀerent time epochs. Pain management
interventions might diﬀerentially impact immediate versus
more delayed responses.42 We therefore separated out the
diﬀerent phases of the procedure (preprocedural, acute
procedural, procedural recovery, or combinations of these)
to isolate the eﬀect of interventions across the various time
epochs. Using established methods, we also combined
outcome measures to allow all data pertaining to an outcome to inform the summary statistics, thereby eliminating
bias from picking any individual tool or approach. This
method may have also reduced the variability around each
estimate. Nevertheless, the psychometric properties of various measures of an outcome were likely not equivalent and
amalgamation of outcomes from multiple informants may
have added noise to the data. Observer judgments are
invariably inﬂuenced by the raters’ personal relationship to
and history with the individual being immunized. The
subjectivity of pain and fear and known lack of agreement
between raters (eg, parents and clinicians43) could have
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introduced error and additional variability, thereby masking treatment eﬀects. Nevertheless, given that treatment
eﬀects were often found in the presence of this variability,
we can have more conﬁdence in these ﬁndings.

Lack of Data on Important Outcomes
Critically, we noted a striking lack of data for many
outcomes identiﬁed by the HELPinKids&Adults team as
important including: vaccination compliance, procedure
outcomes (duration of procedure, success of procedure),
memory, satisfaction, preferences, and ﬁdelity with interventions.44 These outcomes extend beyond pain intensity and
represent the broader priorities of individuals invested in
vaccination. We urge researchers to include these outcomes in
future intervention studies to address the needs of stakeholders who ultimately determine if evidence will be used.
Uptake of knowledge is compromised if the evidence does
not address stakeholders’ questions and concerns. Pain
researchers need to be cognizant of the aspects of vaccination
that nonpain researchers deem to be important.
One of the major research gaps identiﬁed in this ﬁeld is
the lack of research on the long-term impact of our interventions on individuals’ subsequent pain and fear-related cognitions and behaviors. For example, although providing the
most painful vaccination last appeared to result in decreased
distress, there is research to suggest that the way in which
painful procedures end has important implications for subsequent memory development and medical compliance.45
Related to this, we did not examine the eﬀect of interventions
on delayed pain (ie, pain that occurs hours to days following
injection). It is possible that some interventions have eﬀects that
impact delayed pain (eg, injection of vaccines in speciﬁc body
regions). Looking beyond immediate pain is important and
should be investigated.38 Finally, examination of patient preferences is also needed to determine what it is that individuals
being vaccinated want from pain management and which
interventions they deem to be acceptable. Incorporating this
information into trial design will ultimately impact treatment
eﬀectiveness and satisfaction with the vaccination experience.

STUDY DESIGN
Lack of Methodological Rigor
We included only randomized-controlled trials (RCTs)
and quasi-RCTs in the HELPinKids&Adults knowledge
synthesis. While these designs are of the highest quality
compared with other designs, overall, there was a lack of
methodological rigor for critical outcomes across included
studies, as assessed by the Cochrane risk of bias tool and
GRADE. In general, quality was rated as low to very low
primarily due to small numbers of participants, high risk of
bias frequently due to lack of blinding, and heterogeneity in
results. Reporting of important aspects of methodology (eg,
sequence generation and concealment) and study design was
lacking or generally poor and invariably reduced quality
assessments. Some of this may be due to date of publication
(pre-CONSORT), but also frequently occurred in new studies. In fact, it is acknowledged that the word quasirandomized is often used interchangeably with quasiexperimental
and the meanings are not clear. We attempted to contact
authors of trials to gather additional details about studies;
occasionally this led to exclusion of studies from the review.
It is possible that some studies were included that should not
have been. In addition, we noted that in several cases, trial
details did not match registry information. This raises
Copyright

r

Limitations and Future Directions

questions about the reasons for these inconsistencies and how
to best approach them in systematic reviews.
The majority of studies included in the systematic
reviews had high risk of bias. Additional RCTs of existing
interventions are needed where the quality of evidence is
poor and few studies exist. Furthermore expansion to
interventions targeting other aspects of the vaccination
experience (eg, delayed pain, postvaccination cognitions of
individuals, and signiﬁcant others) is also needed. The ﬁeld
needs to move beyond “single-dose” studies to provide a
broader scope of the long-term impact of consistent pain
management. This will be aided by the use of prospective,
longitudinal designs. With additional trials and knowledge
syntheses, the ﬁeld will move toward understanding moderators and mechanisms of change in our interventions as
well as tailoring interventions based on individual preferences and needs to maximize beneﬁt.
When designing trials, we strongly urge researchers to
follow CONSORT and Cochrane methodology to ensure
low risk of bias and increase conﬁdence in results. Greater
eﬀorts to minimize bias are critically needed. Researchers
should use true randomization rather than alternate
assignment, as well as adequate allocation concealment and
blinding of participants, personnel, and outcome assessment. Although this can at times be challenging, particularly
in the case of psychological interventions, it is scientiﬁcally
and ethically justiﬁed. Indeed, to not do this may promote
the use of ineﬀective interventions and halt advances in the
ﬁeld. There are excellent examples of this in the ﬁeld of pain
that can serve as examples46–48; however, creativity and new
methods may be needed depending on the context.

Consideration of Evolving Research Climate
In addition, researchers need to consider the current
and evolving research climate in the areas of vaccination
and pain, and broadly clinical trials. For example, it has
been suggested that use of placebo as a comparison group is
unethical when evidence for a therapeutic intervention’s
eﬃcacy exists.49–52 Indeed, in the context of vaccination,
researchers have argued that pain management interventions should become the standard of care.38 These
movements will have implications for future trials and
systematic reviews. Alterations in study design (eg, comparing 2 treatments as opposed to comparing a treatment
with control) may change the parameters with which we use
to judge clinical signiﬁcance.

CONCLUSIONS
In summary, the HELPinKids&Adults knowledge synthesis examined the eﬀectiveness of interventions across a wide
range of domains including procedural, physical, pharmacological, psychological, and process for vaccine-related pain and
fear in individuals with a high level of needle fear. The synthesis is very timely due to outbreaks of vaccine preventable
diseases across diﬀerent geographic regions53,54 due to underimmunization of populations and loss of herd immunity. The
reasons for vaccine hesitancy are complex and context speciﬁc55; however, concerns about pain and fear are well-documented contributors to vaccination noncompliance.56,57
Eﬀective management of vaccine-related pain and needle fear
hold promise for improving compliance and health across the
lifespan. The HELPinKids&Adults knowledge synthesis is an
important step in that direction. The current paper outlines
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some of the critical limitations of the evidence base and
important gaps in our knowledge. We strongly urge
researchers to design high-quality trials incorporating the recommendations oﬀered in this manuscript. The importance and
impact of managing vaccination pain and fear extend to all
individuals at every stage of development. Improving and
expanding the evidence base regarding interventions aiming to
reduce vaccination pain and fear will be integral to eﬀorts to
improve compliance and public health worldwide.
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